Hypermarcas (OTCMKTS:HYPMY) Shares Cross Below Fifty Day Moving Average - Time to Sell?

Key Points

• Hypermarcas shares fell below their 50-day moving average of $4.76, reaching a low of $4.22 before closing at $4.35.
• Despite the dip, Scotiabank upgraded Hypermarcas to a "strong-buy" rating on July 17th.
• The company announced a dividend of $0.0345, with a substantial dividend yield of 281.0%, payable on January 8th to investors on record from July 1st.

Shares of Hypermarcas (OTCMKTS:HYPMY - Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.76 and traded as low as $4.22. Hypermarcas shares last traded at $4.35, with a volume of 7,152 shares trading hands.

Wall Street Analyst Weigh In

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research report on Thursday, July 17th.

Hypermarcas Trading Down 5.4%

The company has a market capitalization of $2.58 billion, a P/E ratio of 19.39 and a beta of 0.77. The stock has a fifty day moving average of $4.76 and a 200 day moving average of $4.00. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.12 EPS for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Announces Dividend

The company also recently announced a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be paid a $0.0345 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a dividend yield of 281.0%. Hypermarcas's dividend payout ratio is currently 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.